Epalrestat
Epalrestat CAS Nu.: 82159-09-9
Epalrestat is a non-competitive inhibitor of aldose reductase, which reversibly inhibits the conversion of glucose into sorbitol aldose reductase in polyol metabolism associated with the pathogenesis of diabetic complications, and can significantly improve The patient's symptoms and neurological dysfunction improve their motor nerve conduction velocity and autonomic function.
O le Epalrestat e faʻaaogaina e puipuia ai, faʻamalieina, ma togafitia ai le neuropathy lautele (le mautonu, tiga), vevesi paresthesia, ma le faʻamaʻi o le fatu e fesoʻotaʻi ma le maʻisuka. FAʻAALIGA
Epalrestat is a non-competitive inhibitor of aldose reductase, which reversibly inhibits the conversion of glucose into sorbitol aldose reductase in polyol metabolism associated with the pathogenesis of diabetic complications, and can significantly improve The patient's symptoms and neurological dysfunction improve their motor nerve conduction velocity and autonomic function.
O le Epalrestat e faʻaaogaina e puipuia ai, faʻamalieina, ma togafitia ai le neuropathy lautele (le mautonu, tiga), vevesi paresthesia, ma le faʻamaʻi o le fatu e fesoʻotaʻi ma le maʻisuka. FAʻAALIGA
| P igoa igoa | Epalrestat |
| CAS | 82159-09-9 |
| MF: | C15H13NO3S2 |
| MW: | 319.4 |
Tusi lau feʻau ii ma lafo mai ia matou
